In the context of this study, H-1-2 exerts its beneficial role against pancreatic cancer by targeting hypoxia/HIF1α, supporting HIF1α as a promising therapeutic target in pancreatic cancer treatments. The gene discussed is HIF1A; the disease is pancreatic neoplasm.